Woon Jung Jung

Title: Innovations by Inventor Woon Jung Jung

Introduction

Woon Jung Jung is a prominent inventor based in Seoul, South Korea, recognized for his contributions to the field of radiopharmaceuticals. With two patents to his name, he has made significant strides in the diagnosis and treatment of prostate cancer through innovative compounds and synthesis methods.

Latest Patents

Woon Jung Jung's latest patents include:

1. **18F-labelled compound for prostate cancer diagnosis, and use thereof**: This invention relates to a compound that selectively binds to prostate-specific membrane antigen (PSMA), facilitating the acquisition of clear prostate cancer images in a short time when utilized in positron emission tomography (PET).

2. **Method for synthesizing radiopharmaceuticals using a cartridge**: This method streamlines the process of synthesizing radiopharmaceuticals by conducting multiple reaction steps within a cartridge filled with a polymer. The confined solution ensures that reactions remain contained, simplifying the procedure compared to traditional methods and expediting synthesis.

Career Highlights

Woon Jung Jung currently works at Futurechem Co., Ltd., a company focused on developing advanced chemical products for various applications. His work emphasizes innovation in the field of medical diagnostics, particularly in enhancing techniques for cancer imaging.

Collaborations

Throughout his career, Woon Jung Jung has collaborated with notable colleagues, including Dae Yoon Chi and Byoung Se Lee. These partnerships have allowed him to expand the reach and impact of his inventions within the scientific community.

Conclusion

Woon Jung Jung continues to be a significant figure in the field of radiopharmaceuticals, with his recent patents demonstrating a commitment to improving diagnostic techniques for prostate cancer. His work at Futurechem Co., Ltd. and collaborations with other experts underline the importance of innovation in advancing medical science.